$ETON 3 SEC Filings

Filed On	Filing
12 Aug 2026	Form 3: Radosavljevic Danka, Chief Operating Officer Holds 22,473 shares of Common Stock
01 Jun 2026	Form 3: Matthews Judith M., Chief Financial Officer
09 Dec 2024	Form 3: Erdogan-Trinkaus Ipek, Chief Commercial Officer
12 Sep 2024	Form 3: Opaleye Management Inc., 10% owner Holds 2,610,000 shares of Common Stock, par value $0.001 per share
08 Mar 2023	Form 3: Krempa David, Chief Business Officer Holds 12,831 shares of Common Stock
14 Apr 2022	Form 3: Gruber James R., Chief Financial Officer
17 Mar 2021	Form 3: Adams Jennifer McKie, Director No securities owned
06 Apr 2020	Form 3: Opaleye Management Inc., 10% owner Holds 3,500,000 shares of Common Stock, $0.001 par value
13 Nov 2018	Form 3: Imprimis Pharmaceuticals, Inc., 10% owner Holds 3,500,000 shares of Common Stock
13 Nov 2018	Form 3: Casamento Charles J, Director Holds 54,745 shares of Common Stock
13 Nov 2018	Form 3: Maier Paul V, Director Holds 54,745 shares of Common Stock
13 Nov 2018	Form 3: Riedel Norbert G, Director Holds 54,745 shares of Common Stock
13 Nov 2018	Form 3: Baum Mark L, Director Holds 784,745 shares of Common Stock
13 Nov 2018	Form 3: Troutman William Wilson, CFO, Treasurer & Secretary
13 Nov 2018	Form 3: Brynjelsen Sean, Director Holds 1,000,000 shares of Common Stock

Comments